As we wrap up an excellent week of discussions at #AAIC2023, we can't help but be excited about the conversations we have had. Today is your last chance to catch up with us at booth 414.

#AAIC2023 #AlzheimersResearch #Combinostics #SoftwareTools #AI #HealthcareInnovation

Attention #AAIC2023 attendees, join us today as Combinostics CEO Lennart Thurfjell and Professor Linus Jönsson from Karolinska Institutet, delve into the intriguing topic of "The role of software tools and AI in the context of new disease modifying drugs in AD.

🌟 Exciting times at AAIC 2023! Our team is having a great first day showcasing Combinostics' imaging and decision support solutions for Dementia care. Don't miss your chance to learn more at booth 414!

Exciting News! Combinostics has just released its new cPET application in Europe!

Learn more: eu1.hubs.ly/H04vB0x0

#Combinostics #cPET #neurologicaldisorders #PETquantification #AAIC2023 #CuttingEdgeTechnology

1 week to go until Combinostics CEO, Lennart Thurfjell, and Professor Linus Jönsson from Karolinska Institutet delve into the role of AI in the context of new disease-modifying drugs for Alzheimer's Disease at #AAIC2023. Join them on July 18th, from 12:30 – 1:15.

Can you believe it's already the last day of #SNMMI2023? We've had an amazing time in Chicago discussing the latest in #FDGPET and #AmyloidPET quantification. If you haven't stopped by booth 3016 yet, now is your last chance to join the conversation. See you there!

📢 #SNMMI2023 attendees! 📢

Make sure to swing by booth 3016 to meet our amazing team and learn all about amyloid PET quantification and more! Our experts are eager to share their knowledge and answer any questions you may have. See you there!

#PETimaging #NuclearMedicine

Attention all #SNMMI2023 attendees in Chicago! Don't miss out on the chance to visit Combinostics at booth 3016 and learn about our upcoming PET quantification* solution. See you there!

eu1.hubs.ly/H04dK_C0

#PET #NuclearMedicine #Combinostics *Regulatory clearance pending

Combinostics is proud to be part of the @IHI_PROMINENT consortium, working together to create a digital platform for precision medicine that will improve the lives of patients with neurodegenerative diseases. #digitalhealth #neurodegeneration @IHIEurope
eu1.hubs.ly/H045FB80

#RöKo2023
Our team is waiting for you on the last day of the event at Booth: Süd 36.

See you there!

Are you at #röko2023 today?

Don't miss the Combinostics Presentation from Elena Bonke!

Supporting the entire patient pathway: Early detection, diagnosis, and ongoing management of Alzheimer’s disease and other major neurological disorders

2:45 – 3:00 pm

See you there!

Attending the 104th German X-ray Congress (Deutscher Röntgenkongress) #röko2023?

Reserve time with our EU Team and stand by Combinostics' Booth: Süd 36.

See you there!
eu1.hubs.ly/H03NmHM0
#radiology #röko

Welcome to our new Clinical Application Specialist in Europe – Elena Bonke.

Elena is passionate about pioneering breakthroughs in healthcare by bridging the gap between clinical application and technical advancements.

Happy to have you on board!

Combinostics at #RÖKO this year!

We are waiting for you on May 17-19, 2023 | Wiesbaden, Germany

Visit our Booth: Süd 36

Thanks to everyone who joined Richard's Presentation today!

You always can schedule the online Demo with our team.

Also, don't forget about our 10-DAY FREE TRIAL to use the benefits of cMRI on your own patient cases!

It only takes minutes to start:
eu1.hubs.ly/H03HBn30

Are you at Advanced MRI today?

Welcome to The Combinostics' Presentation:

"Next level MRI Quantification and Dementia Treatment Pathway Support".
Richard Hausmann, CEO

Today, at 12:10

Our positive EU Team is waiting for you at The Combinostics' Booth #4 at the Advanced MRI Event!

Alzheimer's disease (AD) is associated with substantial disruptions in the brain network. Here, researchers suggest that dynamic functional connectivity could be powerful in helping to discriminate AD from normal cognition. #ALZResearch #machinelearning

eu1.hubs.ly/H03F_HC0

Combinostics at the #ASNR 2023 Event!

Visit Booth #603 and chat with Tom Gardner, Kristi Nucatola, and Gretchen Lessman.

See you there!

Meet our EU Team at the Advanced MRI Event this week!

Stop by booth #4 or schedule a meeting to chat with our team via the online form:

eu1.hubs.ly/H03Fs-x0

Attending #ASNR in Chicago?

Welcome to our AI Theatre Presentation today at 12:35!

"Supporting the entire patient pathway", with Thomas Gardner, Vice President of US Sales.

See you there or at Combinostics' booth #603!

#ASNR 2023 is around the corner!

Meet Combinostics' US Team at booth: 603

Schedule some time with us here:

eu1.hubs.ly/H03DHd90

TODAY!

We are waiting for you at the new Combinostics webinar as Dr. Kevin Berger explores what you need to know about #MRI quantification of #MS and #Dementia cases.

11 am EST/ 8 am PT/ 5 pm CET.

The Link to the Webinar is here:
eu1.hubs.ly/H03CJNF0

Combinostics at the ASNR Annual Meeting 2023!
April 29-May 3, 2023 | Chicago, IL
Our Booth: 603

Schedule some time to learn more about our cNeuro® suite:

eu1.hubs.ly/H03Cdh-0

Meet with us at Advanced MRI 2023 in Graz, Austria!

Visit Combinostics booth #4 to discover how we go beyond neurological image quantification with all our Reports.

The first day just started at the #garmischsymposium

Our team is looking forward to meeting you at Booth B8 to show Our AI solutions including:

- cDSI
- cMRI
- cPET*
- cARIA*

See you there!

Visit Combinostics tomorrow at Garmisch Symposium International 2023 in Germany.

Meet our EU Team and discover our complete AI software solution.

We will be at booth B8.

Join the new Combinostics webinar as Dr. Kevin Berger explores what you need to know about MRI quantification of MS and Dementia cases.

Thursday 27 April: 11 am EST/ 8 am PT/ 5 pm CET.

Register here:
eu1.hubs.ly/H03vZFJ0

Join us for our latest webinar as Dr. Kevin Berger explores what you need to know about MRI quantification of MS and Dementia cases.

The 30-minute webinar will be on Thursday 27 April: at 11 am EST/ 8 am PT/ 5 pm CET.

Register here:
eu1.hubs.ly/H03t3CP0

Attending Garmisch Symposium International 2023 in Germany?

Visit Combinostics booth: B8 to discover how we go beyond neurological image quantification with all our Reports.

Schedule some time with our team:
eu1.hubs.ly/H03rsPL0

Determining the cause of cognitive impairment in older adults with both epilepsy and cognitive decline can be challenging. This study suggests that #amyloidPET could be useful to determine the cause of cognitive decline for some patients. #medicalimaging eu1.hubs.ly/H03lPJy0

NEW video on our Youtube channel!

ECR 2023 AI Industry Pitch from our CEO, Dr. Richard Hausmann:
"Supporting the Entire Patient Pathway"

eu1.hubs.ly/H03g4JN0

We are now looking for a full-time employee as Head of QA in Finland (hybrid). This is a critical role, managing our QMS and our ISMS as well as managing regulatory aspects of our launched products.
#jobalerts #hiring #wearehiring
eu1.hubs.ly/H03fp450

Welcome to our new Senior Sales Representative in Europe – Thomas Marx.

Thomas is an ambitious developer of medical start-ups, he has more than four decades of experience in the sales of medical devices: Regional, National, DACH, and EMEA.

Happy to have you on board!

Welcome to our new ambitious Software Developer – Mihail Bobretsov.

Combinostics wish you rapid growth in our team.

Happy to have you on board!

Clinical Utility of a Novel Test to Diagnose Alzheimer's Disease in Patients with Suspected Dementia

There is another exciting new development for the earlier diagnosis of Alzheimer's disease (AD).
eu1.hubs.ly/H034Fn90

The Presentation is finished, but you always can chat with us and schedule the online Demo with our team.

Don't forget about our 10-DAY FREE TRIAL to use the benefits of cMRI on your own patient cases!

It only takes minutes to start:
eu1.hubs.ly/H033tPj0

Welcome to our 20 minutes Al Theatre presentation today:
"Supporting the entire patient pathway: Early detection, diagnosis, and ongoing management of major neurological disorders"

13:30 The Al Theatre: Industry Pitches Al-IND 14
Richard Hausmann, CEO Combinostics Oy

Combinostics Team is looking forward to talking to you on this last day of the Congress.

See you at our booth!

It is hot today, but we'll always find time for you!

If you are at #ECR2023, please stop by on the #Combinostics Booth X1-AI-36.

The 3d day just started at the #ECR2023

Our team is looking forward to meeting you at Booth AI-36 - Hall X1 to show Our AI solutions including:
- cDSI
- cMRI
- cPET*
- cARIA*

Welcome to our new Clinical Application Specialist in Europe – Guglielmo Manco.

Guglielmo is an experienced professional in Radiology, from CT to MRI and Interventional Radiology.

You can chat with him right now if you are also at #ECR2023, our Booth is X1-AI-36

We are happy to see you at our booth: AI-36 in the X1 Area!

Let's have a chat!

eu1.hubs.ly/H030TvW0

As part of the US Team expansion, we're now looking for a talented and passionate Sales Director to join us on our exciting journey to change the quality of life for patients around the world.
Details are here:
eu1.hubs.ly/H030CC_0

#ECR2023 is around the corner! Will we see you there? Stop by booth EXPO X1-AI-36.

Schedule a chat with one of our experts, and don't forget about the AI Theatre Presentation on the last day!

eu1.hubs.ly/H02_JrY0

Visit Combinostics at ECR-2023 to meet our EU Team and discover our complete AI software solution that supports entire patient care pathways of major neurological disorders.
We will be at booth EXPO X1-AI-36.
Schedule a meeting with us below:
eu1.hubs.ly/H02Y4Jc0

New research indicates that both increased white matter lesions and #brainatrophy are associated with a higher risk of developing dementia. Identifying these associations could help with earlier diagnosis and treatment for dementias. #dementiaresearch eu1.hubs.ly/H02WPyD0

Are you going to be in Vienna for ECR this year?

Visit Combinostics booth: EXPO X1-AI-36 to discover how we go beyond neurological image quantification with all our Reports.

Schedule a meeting with our team below:
eu1.hubs.ly/H02T-8R0

Early diagnosis of Alzheimer’s (AD) is important for #diseasemodifyingdrugs, such as #leqembi, to be effective.
The amyloid-β ratio may indicate AD before amyloid positivity on PET. Together, plasma amyloid-β ratio and amyloid PET could improve AD care. eu1.hubs.ly/H02RXMH0

Did you watch our new videos on the Combinostics’ YouTube channel?

Learn about our disease-specific clinical reports for:
eu1.hubs.ly/H02R21Q0

Discover how Combinostics can help support Multiple Sclerosis management by:
eu1.hubs.ly/H02R2110

There have been few #diseasemodifyingdrugs (DMD) for Alzheimer's until the recent approval of aducanumab and #lecanemab.

Biomarkers, including imaging biomarkers, can help manage patients on DMD across the patient pathway. Read the blog. #alzresearch

eu1.hubs.ly/H02Mtlt0

Start your 10-DAY FREE TRIAL today to use the benefits of cMRI on your own patient cases!

It only takes minutes to start:
eu1.hubs.ly/H02LQ1S0